All Q4 FY25 results →
OD

OSEL Devices Ltd

Q4 FY25Healthcare Equipment & Supplies

OSEL Devices Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹401
Market cap₹743 Cr
P/E25.4
Updated23 Aug 2026
Read4 min read

The short version

Expecting significant top-line growth next year, driven by the Philips mobile phone partnership and expansion in hearing aids and LED display segments. OSEL Devices expects to maintain current PAT margins while achieving significant revenue growth driven by new product lines like Philips mobile phones and tablets.

From OSEL Devices Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Expecting significant top-line growth next year, driven by the Philips mobile phone partnership and expansion in hearing aids and LED display segments.
  • Targeting around 25% CAGR over the next 4-5 years, with major growth potential in LED and hearing aid markets, currently capturing a small share.
  • Anticipate volume growth in hearing aids and large-scale expansion in OEM LED display manufacturing, shifting production from China to India.
  • Retail market entry for hearing aids expected to add margin and revenue growth.
  • Projected revenue mix for FY26: ~30% from Philips phones, 30% from LED displays (including OEM), and 20% from hearing aids.
  • Export markets targeted for better margins and growth, leveraging the JNPT industrial park facility.

2 more points from OSEL Devices Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what OSEL Devices Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • OSEL Devices Limited has made capital investments in land parcels at JNPT port (plot numbers 210 and 211) for establishing an industrial park aimed at catering to international business and export markets.
  • The company has paid around INR 8-10 crores for JNPT land and about INR 4-4.5 crores for office space in Bangalore, with related registry processes pending.
  • Plans are underway to set up manufacturing facilities at the JNPT location to support export-oriented growth and international customers.
  • The industrial park and JNPT facility development are targeted to support their growing business segments, especially exports which are projected to have better margins.

2 more points from OSEL Devices Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 3
2Q-Line Biotech
Rev 2Mar 1
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what OSEL Devices Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Current order-in-hand for OSEL Devices Limited is approximately INR 40-45 crores.
  • There is a significant order pipeline with healthy numbers targeted, though exact figures are not disclosed.
  • The pipeline includes various tenders and projects, indicating strong potential future business.

2 more points from OSEL Devices Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Others in Healthcare Equipment & Supplies this season

  • Vaidya Sane (Q4 FY25)

    120 crores. Key concall takeaways from Vaidya Sane Ayurved Laboratories Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Poly Medicure Ltd (Q4 FY25)

    EBITDA margins guided between 25%-27%, with potential upside if export growth exceeds 15%. Key concall takeaways from Poly Medicure Ltd's Q4 FY25 earnings call…

  • Prevest Denpro (Q4 FY25)

    The management emphasizes growth in both domestic and export markets, indicating healthy order inflows aligned with a 13% sales increase in FY25. Key concall…

  • Aprameya Enginee (Q4 FY25)

    Current order book: Approximately INR 60 crores. Key concall takeaways from Aprameya Engineering Ltd's Q4 FY25 earnings call — and how it ranks against sector…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

OSEL Devices Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were OSEL Devices Ltd Q4 FY25 results?

Expecting significant top-line growth next year, driven by the Philips mobile phone partnership and expansion in hearing aids and LED display segments. OSEL Devices expects to maintain current PAT margins while achieving significant revenue growth driven by new product lines like Philips mobile phones and tablets.

What is OSEL Devices Ltd share price analysis?

OSEL Devices Ltd currently shows a neutral. The stock trades at a P/E of 25.4 with a market cap of ₹743 Cr. Investors should review the full earnings analysis for detailed insights.

Is OSEL Devices Ltd planning capital expenditure?

OSEL Devices Limited has made capital investments in land parcels at JNPT port (plot numbers 210 and 211) for establishing an industrial park aimed at catering to international business and export markets.

Keep OSEL Devices Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.